Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Testicular Neoplasms 1Seminoma 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Necrosis 1Medulloblastoma 1Hepatoblastoma 1Hearing Loss 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Appendiceal Neoplasms 1

Interventions

Oxaliplatin 5Mitomycin 4Hyperthermic Intraperitoneal Chemotherapy 4Fluorouracil 4Cisplatin 4Doxorubicin 3Standard of Care 2Paclitaxel 2Leucovorin 2Docetaxel 2Blood Specimen Collection 2Bevacizumab 2sodium thiosulfate 1relacorilant 1liposomal doxorubicin 1irinotecan sucrosofate 1dehydroftorafur 1X-Rays 1Topotecan 1Specimen Handling 1Practice Guidelines as Topic 1Platinum 1Pancreatectomy 1Pafolacianine 1Observation 1Mitozytrex 1Magnetic Resonance Spectroscopy 1Letrozole 1Laparoscopy 1LY-2157299 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Peritoneal Neoplasms × sodium thiosulfate × Clear all
NCT04847063 2026-04-14

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
60 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Gastrointestinal Neoplasms, Necrosis, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡